Thus, PPAR isoforms were suggested to be a suitable molecular target to treat skin diseases with aberrated cell proliferation such as psoriasis and skin cancers (Kim et al., 2006; Sertznig et al., 2008; Ramot et al., 2015). The gene discussed is PPARA; the disease is skin neoplasm.